OPTN and fatty liver disease: Moreover, we found that the expression of lipogenic genes (SCD1, ACC, and FASN) and lipid accumulation in PA-stimulated hepatocytes were reduced in cells with knocked down OPTN expression, further supporting the idea of OPTN as a therapeutic target that can delay the progression of fatty liver disease.